Register for an account


Enter your name and email address below.

Your email address is used to log in and will not be shared or sold. Read our privacy policy.


Website access code

Enter your access code into the form field below.

If you are a Zinio, Nook, Kindle, Apple, or Google Play subscriber, you can enter your website access code to gain subscriber access. Your website access code is located in the upper right corner of the Table of Contents page of your digital edition.


#13: Hope for HIV Vaccine

In the unforgiving world of AIDS vaccines, even a modestly protective effect is big news.


Sign up for our email newsletter for the latest science news

An international team of researchers announced in September that for the first time, an AIDS vaccine has demonstrated some real ability to prevent HIV infections in a large clinical trial, reducing the odds of infection by about 31 percent.

The trial followed more than 16,000 people (who initially tested HIV-free) for three and a half years. They received either a combination of two potential vaccines or placebo shots. By the end, 74 placebo recipients had acquired HIV infections, compared with 51 vaccinated individuals. The trial report, published in October, included alternative analyses that put the vaccine’s effectiveness slightly lower, at around 26 percent, leading some to question the reliability of the results. The researchers reply that all of the analyses consistently support a modest protective effect.

AIDS researcher Jay Levy at the University of California at San Francisco finds the results encouraging, but notes that the vaccines seemed to have no effect on the amount of virus in the bloodstream of people who contracted HIV during the study. Nelson Michael of the U.S. Military HIV Research Program, which helped run the trial, is more optimistic: “We’ve shown that this 26-year global effort has not been in vain.”

2 Free Articles Left

Want it all? Get unlimited access when you subscribe.


Already a subscriber? Register or Log In

Want unlimited access?

Subscribe today and save 75%


Already a subscriber? Register or Log In